Thoratec Corporation, HeartMate II Left Ventricular Assist System (LVAS): Class 1 Recall- Outflow Graft May Kink or Deform
May result in reduction of blood flow from the pump, pump/graft thrombosis, or perforation of the outflow graft.
Altuzan (bevacizumab): Counterfeit Product - Contains no Active Ingredient
The counterfeit product may have resulted in patients not receiving needed therapy.
Celexa (citalopram hydrobromide) - Drug Safety Communication: Revised Recommendations, Potential Risk of Abnormal Heart Rhythms
Revised drug label clarifying dosing and warning recommendations.
Argatroban Injection 50 mg/50 mL (1 mg/mL): Recall - Potential for Visible Particulates
Risk of embolization/infarction to organs and potential organ complications.
Brilliant Blue G Compounded by Franck’s: Recall of Unapproved Drug - Ongoing Investigation of Fungal Endophthalmitis Cases
UPDATED 03/21/2012. Reports of eye infections in patients who were given Brilliant Blue G during eye surgeries.
Brilliant Blue G: Recall of Unapproved Drug - Ongoing Investigation of Fungal Endophthalmitis Cases
Reports of eye infections in patients who were given Brilliant Blue G during eye surgeries.
Skin Creams, Soaps and Lotions Marketed as Skin Lighteners and Anti-aging Treatments: May Contain the Toxic Metal, Mercury
Products with this toxic metal have been found in at least seven states, are manufactured abroad and often sold in shops in Latino, Asian, African or Middle Eastern neighborhoods and online.
Acclarent Inspira AIR Balloon Dilation System: Class 1 Recall - Potential For Balloon To Not Deflate Or To Deflate To Slowly
Prolonged obstruction of the airway may prevent adequate blood oxygenation, which could cause temporary or permanent impairment to the patient
Gerber Good Start Gentle Powdered Infant Formula: Recall - Off-Odor
Reports of gastrointestinal complaints.
Cardiac Science Powerheart, CardioVive, CardioLife; GE Responder and Responder Pro; and Nihon-Kohden Automated External Defibrillators (AEDs): Class I Recall - Defective Component
Unexpected component failure may lead to AEDs not delivering defibrillation therapy, causing serious adverse health consequences, including death.